IDENTIFICATION AND CHARACTERIZATION OF AN EXTRACELLULAR ENVELOPE GLYCOPROTEIN AFFECTING VACCINIA VIRUS EGRESS

被引:147
作者
DUNCAN, SA [1 ]
SMITH, GL [1 ]
机构
[1] UNIV OXFORD, SIR WILLIAM DUNN SCH PATHOL, S PARKS RD, OXFORD OX1 3RE, ENGLAND
关键词
D O I
10.1128/JVI.66.3.1610-1621.1992
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Sequence analysis of the vaccinia virus strain Western Reserve genome revealed the presence of an open reading frame (ORF), SalL4R, which has the potential to encode a transmembrane glycoprotein with homology to C-type animal lectins (G. L. Smith, Y. S. Chan, and S. T. Howard, J. Gen. Virol. 72:1349-1376, 1991). Here we show that the SalL4R gene is transcribed late during infection from a TAAATG motif at the beginning of the ORF. Antisera raised against a TrpE-SalL4R fusion protein identified three glycoprotein species of M(r) 22,000 to 24,000 in infected cells. Immunogold electron microscopy demonstrated that SalL4R protein is present in purified extracellular enveloped virus particles but not in intracellular naked virus (INV). A mutant virus was constructed by placing a copy of the SalL4R ORF downstream of an isopropyl-beta-D-thiogalactopyranoside (IPTG)-inducible vaccinia virus promoter within the thymidine kinase locus and subsequently deleting the endogenous SalL4R gene. The growth kinetics of this virus demonstrated that SalL4R was nonessential for the production of infectious INV but was required for virus dissemination. Consistent with this finding, the formation of wild-type-size plaques by this mutant was dependent on the presence of IPTG. Electron microscopy showed that without SalL4R expression, the inability of the virus to spread is due to a lack of envelopment of INV virions by Golgi-derived membrane, a morphogenic event required for virus egress.
引用
收藏
页码:1610 / 1621
页数:12
相关论文
共 58 条
[1]   VACCINIA VIRUS-ENCODED EIF-2-ALPHA HOMOLOG ABROGATES THE ANTIVIRAL EFFECT OF INTERFERON [J].
BEATTIE, E ;
TARTAGLIA, J ;
PAOLETTIT, E .
VIROLOGY, 1991, 183 (01) :419-422
[2]  
Boulter E A, 1973, Prog Med Virol, V16, P86
[3]   PROTECTION AGAINST POXVIRUSES [J].
BOULTER, EA .
PROCEEDINGS OF THE ROYAL SOCIETY OF MEDICINE-LONDON, 1969, 62 (03) :295-&
[4]   A DOMINANT SELECTABLE MARKER FOR THE CONSTRUCTION OF RECOMBINANT POXVIRUSES [J].
BOYLE, DB ;
COUPAR, BEH .
GENE, 1988, 65 (01) :123-128
[5]   DELETION OF THE VACCINIA VIRUS GROWTH-FACTOR GENE REDUCES VIRUS VIRULENCE [J].
BULLER, RML ;
CHAKRABARTI, S ;
COOPER, JA ;
TWARDZIK, DR ;
MOSS, B .
JOURNAL OF VIROLOGY, 1988, 62 (03) :866-874
[6]   DECREASED VIRULENCE OF RECOMBINANT VACCINIA VIRUS EXPRESSION VECTORS IS ASSOCIATED WITH A THYMIDINE KINASE-NEGATIVE PHENOTYPE [J].
BULLER, RML ;
SMITH, GL ;
CREMER, K ;
NOTKINS, AL ;
MOSS, B .
NATURE, 1985, 317 (6040) :813-815
[7]   POXVIRUS PATHOGENESIS [J].
BULLER, RML ;
PALUMBO, GJ .
MICROBIOLOGICAL REVIEWS, 1991, 55 (01) :80-122
[8]   FUSION OF INTRACELLULAR AND EXTRACELLULAR FORMS OF VACCINIA VIRUS WITH THE CELL-MEMBRANE [J].
DOMS, RW ;
BLUMENTHAL, R ;
MOSS, B .
JOURNAL OF VIROLOGY, 1990, 64 (10) :4884-4892
[9]  
DRICKAMER K, 1988, J BIOL CHEM, V263, P9557
[10]   THE PREPARATION OF ORTHOPOXVIRUS DNA [J].
ESPOSITO, J ;
CONDIT, R ;
OBIJESKI, J .
JOURNAL OF VIROLOGICAL METHODS, 1981, 2 (03) :175-179